These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 19606692)
1. [Melatonin secretion and metabolism in patients with irritable bowel syndrome]. Stepień A; Moskwa-Fortuna A; Wisniewska-Jarosińska M; Harasiuk A; Chojnacki J Pol Merkur Lekarski; 2009 May; 26(155):440-3. PubMed ID: 19606692 [TBL] [Abstract][Full Text] [Related]
2. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome]. Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome. Wisniewska-Jarosinska M; Chojnacki J; Konturek S; Brzozowski T; Smigielski J; Chojnacki C J Physiol Pharmacol; 2010 Jun; 61(3):295-300. PubMed ID: 20610859 [TBL] [Abstract][Full Text] [Related]
5. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. Chojnacki C; Walecka-Kapica E; Lokieć K; Pawłowicz M; Winczyk K; Chojnacki J; Klupińska G Endokrynol Pol; 2013; 64(2):114-20. PubMed ID: 23653274 [TBL] [Abstract][Full Text] [Related]
6. The role of serotonin in pathogenesis of unclassified irritable bowel syndrome. Chojnacki C; Konrad P; Kaczka A; Mędrek-Sochab M; Chojnacki M; Błońska A Pol Merkur Lekarski; 2022 Oct; 50(299):277-281. PubMed ID: 36283008 [TBL] [Abstract][Full Text] [Related]
7. Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome. Chojnacki C; Walecka-Kapica E; Mokwinska M; Romanowski M; Pawlowicz M; Chojnacki J; Klupinska G J Physiol Pharmacol; 2013 Apr; 64(2):177-83. PubMed ID: 23756392 [TBL] [Abstract][Full Text] [Related]
8. [24-hour urinary 6-hydroxymelatonin sulfate excretion in patients with ulcerative colitis]. Boznańska P; Wichan P; Stepień A; Wiśniewska-Jarosńska M; Smigielski J; Szadkowski K; Stec-Michalska K Pol Merkur Lekarski; 2007 May; 22(131):369-72. PubMed ID: 17679370 [TBL] [Abstract][Full Text] [Related]
9. Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. Esteban-Zubero E; López-Pingarrón L; Alatorre-Jiménez MA; Ochoa-Moneo P; Buisac-Ramón C; Rivas-Jiménez M; Castán-Ruiz S; Antoñanzas-Lombarte Á; Tan DX; García JJ; Reiter RJ Life Sci; 2017 Feb; 170():72-81. PubMed ID: 27919824 [TBL] [Abstract][Full Text] [Related]
10. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals. Monem SMA; Elbadrawy EG; Shalaby SM; Hendawy DM; Hassan SM; Almonem NA J Med Life; 2022 Dec; 15(12):1525-1531. PubMed ID: 36762339 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance]. Błońska A; Konrad P; Chojnacki J; Chojnacki C Pol Merkur Lekarski; 2017 Mar; 42(249):116-120. PubMed ID: 28333903 [TBL] [Abstract][Full Text] [Related]
13. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. El-Salhy M; Hatlebakk JG; Hausken T World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765 [TBL] [Abstract][Full Text] [Related]
14. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin in patients with irritable bowel syndrome. El-Salhy M; Lillebø E; Reinemo A; Salmelid L Int J Mol Med; 2009 Jun; 23(6):703-7. PubMed ID: 19424595 [TBL] [Abstract][Full Text] [Related]
16. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382 [TBL] [Abstract][Full Text] [Related]
17. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome]. Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234 [TBL] [Abstract][Full Text] [Related]
18. [Small intestine motility and gastrointestinal hormone levels in irritable bowel syndrome]. Zhao JH; Dong L; Hao XQ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1492-5. PubMed ID: 17959521 [TBL] [Abstract][Full Text] [Related]
19. Elevated motility-related transmucosal potential difference in the upper small intestine in the irritable bowel syndrome. Larsson MH; Simrén M; Thomas EA; Bornstein JC; Lindström E; Sjövall H Neurogastroenterol Motil; 2007 Oct; 19(10):812-20. PubMed ID: 17883433 [TBL] [Abstract][Full Text] [Related]
20. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome. Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]